Chemoinformaics analysis of 2,2,3,3-Tetramethylhexane
| Molecular Weight | 142.286 | nRot | 2 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 1 |
| Exact Molecular Weight | 142.172 | nRing | 0 |
| Solubility: LogS | -7.713 | nHRing | 0 |
| Solubility: LogP | 12.006 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 31.3694 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.096 |
| Synth | 2.647 |
| Natural Product Likeliness | 0.394 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -5.127 |
| MDCK | 0.00000568 |
| BBB | 0.008 |
| PPB | 0.984467 |
| VDSS | 3.594 |
| FU | 0.00926705 |
| CYP1A2-inh | 0.053 |
| CYP1A2-sub | 0.136 |
| CYP2c19-inh | 0.135 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.045 |
| CYP2c9-sub | 0.95 |
| CYP2d6-inh | 0.061 |
| CYP2d6-sub | 0.009 |
| CYP3a4-inh | 0.212 |
| CYP3a4-sub | 0.025 |
| CL | 5.085 |
| T12 | 0.025 |
| hERG | 0.556 |
| Ames | 0.003 |
| ROA | 0.011 |
| SkinSen | 0.976 |
| Carcinogencity | 0.025 |
| EI | 0.912 |
| Respiratory | 0.602 |
| NR-Aromatase | 0.064 |
| Antiviral | No |
| Prediction | 0.905617 |